Steroid withdrawal from tacrolimus-based therapy in renal transplant patients.
Citterio
F
F
Department of Surgery, Catholic University, Largo A. Gemelli 8, Rome 00168, Italy.
Rigotti
P
P
Scatà
M C
MC
Romagnoli
J
J
Baldan
N
N
Marchini
F
F
Castagneto
M
M
D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D003404:Creatinine / Q000097:blood; D004334:Drug Administration Schedule; D005060:Europe; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D018579:Patient Selection; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011507:Proteinuria; D016559:Tacrolimus / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D003404:Creatinine; D009173:Mycophenolic Acid; D011241:Prednisone; D016559:Tacrolimus